Investment Management of Virginia’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,060
Closed -$999K 147
2019
Q3
$999K Sell
10,060
-1,578
-14% -$150K 0.25% 95
2019
Q2
$1.08M Sell
11,638
-11,638
-50% -$1.11M 0.26% 101
2019
Q1
$2.2M Buy
23,276
+12,393
+114% +$1.08M 0.26% 104
2018
Q4
$697K Sell
10,883
-985
-8% -$72.7K 0.18% 118
2018
Q3
$1.06M Sell
11,868
-230
-2% -$20.3K 0.22% 108
2018
Q2
$961K Sell
12,098
-51,859
-81% -$4.31M 0.21% 115
2018
Q1
$5.71M Buy
63,957
+10,341
+19% +$993K 1.33% 20
2017
Q4
$5.59M Buy
53,616
+7,988
+18% +$901K 1.33% 21
2017
Q3
$6.65M Sell
45,628
-90
-0.2% -$12.3K 1.56% 17
2017
Q2
$5.94M Sell
45,718
-15
-0% -$1.84K 1.43% 19
2017
Q1
$5.69M Buy
45,733
+5,685
+14% +$680K 1.4% 20
2016
Q4
$4.64M Sell
40,048
-405
-1% -$45.1K 1.11% 28
2016
Q3
$4.23M Buy
40,453
+203
+0.5% +$22K 1.04% 30
2016
Q2
$3.97M Buy
40,250
+11,370
+39% +$1.18M 1.01% 31
2016
Q1
$2.89M Buy
28,880
+19,837
+219% +$2.04M 0.76% 46
2015
Q4
$1.08M Buy
9,043
+3,495
+63% +$404K 0.29% 106
2015
Q3
$600K Buy
+5,548
New +$688K 0.16% 125

Other funds holding CELG

Investment Management of Virginia's CELG Position: Q4 2019 in Review

Investment Management of Virginia sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,060 shares — an estimated $999K sold.

Investment Management of Virginia first reported a position in CELG in Q3 2015 and held it in 17 quarters. The position peaked at $6.65M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Investment Management of Virginia reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Investment Management of Virginia sold 10,060 Celgene Corp shares in Q4 2019, an estimated $999K.
  • Investment Management of Virginia first reported a position in Celgene Corp in Q3 2015 and held it in 17 quarters.
  • Investment Management of Virginia's Celgene Corp position peaked at $6.65M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Investment Management of Virginia's 13F filing for Q4 2019, filed 6 Feb 2020.